GANX GAIN THERAPEUTICS INC Management Changes 8-K Filing 2023 - CFO Transition Gain Therapeutics, Inc. announced the appointment of C. Evan Ballantyne as its Chief Financial Officer, effective April 10, 2023.Get access to all SEC 8-K filings of the GAIN THERAPEUTICS INC